Gilead Sciences, Inc. (GILD)
Nasdaq: GILD · Biological Products, (No Diagnostic Substances) · Foster City, CA · filing with the SEC since 1994
Grade6.8
◀ Past 7.3● Present 7.5▶ Future 5.3
Who runs Gilead Sciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
O'Day Daniel Patrick
Chairman & CEO. First filing Mar 2019, latest Nov 6, 2026, 21 filings in all.
Officers reporting now
8
of 16 people with a filing in the last fifteen months
Directors reporting now
8
38 people on the record since 2006
Officerssales are open-market, Nov 9, 2025 to Nov 9, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Feb 2026 | Nov 9, 2026 | 1 · $600,000 |
| O'Day Daniel Patrick | Chairman & CEO | Mar 2019 | Nov 6, 2026 | 34 · $76.3M |
| Dickinson Andrew D | Chief Financial Officer | Nov 2019 | Oct 16, 2026 | 12 · $4.9M |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Jul 2019 | Oct 16, 2026 | 23 · $18.6M |
| Burkhart Erin | SVP, Controllership | Sep 2025 | Sep 23, 2026 | none |
| Berger Dietmar | Chief Medical Officer | Jan 2025 | Sep 11, 2026 | none |
| Telman Deborah H | EVP, Corporate Affairs & GC | Aug 2022 | Nov 13, 2025 | 3 · $6.6M |
| Wilfong Diane E. | Interim Corp Controller & CAO | Jan 2020 | Sep 11, 2025 | none |
Directorssales are open-market, Nov 9, 2025 to Nov 9, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Welters Anthony | director | Oct 2020 | Aug 27, 2026 | 4 · $2.7M |
| Bluestone Jeffrey | director | Dec 2020 | Aug 21, 2026 | 7 · $2.0M |
| Barton Jacqueline K | director | Feb 2018 | May 4, 2026 | none |
| Horning Sandra | director | Jan 2020 | May 4, 2026 | none |
| Kramer Kelly A. | director | Aug 2016 | May 4, 2026 | 2 · $700,000 |
| Love Ted W | director | Feb 2024 | May 4, 2026 | none |
| Manwani Harish | director | May 2018 | May 4, 2026 | none |
| Rodriguez Javier | director | Jun 2020 | May 4, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 9, 2025 to Nov 9, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gilead Sciences, Inc. | 10% owner | May 2026 | May 27, 2026 | none |
Earlier names on the record22, newest filing first
Patterson Sandra · officer · last filing Mar 2025Parsey Merdad · officer · last filing Dec 2024Lofton Kevin E · director · last filing Mar 2024Pletcher Brett A · officer · last filing Jun 2022Whitley Richard James · director · last filing May 2021Wold Olsen Per · director · last filing May 2021Wilson Gayle E · director · last filing May 2020Cogan John Francis · director · last filing May 2020Hamill Laura · officer · last filing May 2019Washington Robin L · officer · last filing Mar 2019Alton Gregg H · officer · last filing Mar 2019Martin John C · officer · last filing Feb 2019Mchutchison John G · officer · last filing Feb 2019Milligan John F · officer · last filing Nov 2018Moore Nicholas G · director · last filing Apr 2018Young Kevin · officer · last filing Feb 2018Bischofberger Norbert W · officer · last filing Feb 2018Meyers James R · officer · last filing Feb 2018Madigan John W · director · last filing May 2017Carter Paul Rutherford · officer · last filing Aug 2016Davignon Etienne · director · last filing May 2016Hills Carla A · director · last filing May 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.